Authors: DRULOVIC J MOSTARICASTOJKOVIC M LEVIC Z MESAROS S STOJSAVLJEVIC N POPADIC D PRAVICA V

Citation: J. Drulovic et al., SERUM INTERLEUKIN-12 LEVELS IN PATIENTS WITH MULTIPLE-SCLEROSIS, Neuroscience letters, 251(2), 1998, pp. 129-132

Authors: BADOVINAC V MOSTARICASTOJKOVIC M DINARELLO CA STOSICGRUJICIC S

Citation: V. Badovinac et al., INTERLEUKIN-1 RECEPTOR ANTAGONIST SUPPRESSES EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS (EAE) IN RATS BY INFLUENCING THE ACTIVATION AND PROLIFERATION OF ENCEPHALITOGENIC CELLS, Journal of neuroimmunology, 85(1), 1998, pp. 87-95

Authors: LUKIC A POPADIC D RAMIC Z MOSTARICASTOJKOVIC M

Citation: A. Lukic et al., PREDOMINANCE OF THE TH1 DERIVED CYTOKINE IN THE PERIAPICAL LESIONS, Journal of dental research, 77, 1998, pp. 2804-2804

Authors: BADOVINAC V BOGGIANO C TRAJKOVIC V FREY AB VUJANOVIC NL GOLD DP MOSTARICASTOJKOVIC M VUKMANOVIC S

Citation: V. Badovinac et al., RAT NKR-P1(-CELLS - SELECTIVE PROLIFERATION IN INTERLEUKIN-2, DIVERSET-CELL-RECEPTOR-V-BETA REPERTOIRE AND POLARIZED INTERFERON-GAMMA EXPRESSION() CD3(+) T), Immunology, 95(1), 1998, pp. 117-125

Authors: DRULOVIC J MOSTARICASTOJKOVIC M LEVIC Z STOJSAVLJEVIC N PRAVICA V MESAROS S

Citation: J. Drulovic et al., INTERLEUKIN-12 AND TUMOR-NECROSIS-FACTOR-ALPHA LEVELS IN CEREBROSPINAL-FLUID OF MULTIPLE-SCLEROSIS PATIENTS, Journal of the neurological sciences, 147(2), 1997, pp. 145-150